CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null Disease.
Zhao N, Chopra S, Trepka K, Wang YH, Sakhamuri S, Hooshdaran N, Kim H, Zhou J, Lim SA, Leung KK, Egusa EA, Zhu J, Zhang L, Foye A, Sriram R, Chan E, Seo Y, Feng FY, Small EJ, Chou J, Wells JA, Aggarwal R, Evans MJ.
Zhao N, et al. Among authors: sakhamuri s.
Clin Cancer Res. 2022 Jul 15;28(14):3066-3075. doi: 10.1158/1078-0432.CCR-21-3858.
Clin Cancer Res. 2022.
PMID: 35604681
Free PMC article.